Clinical Trials Browser

Not yet recruiting × Interventional × Pancreatic Neoplasms × Clear all

NCT07470268 2026-03-18

HY-PANC

Phase NA Not yet recruiting

Gastrointestinal

Motor Activity, Pancreatic Neoplasms

NCT07478185 2026-03-17

Prehab for Pancreatic Cancer Surgery

Phase NA Not yet recruiting

Gastrointestinal

Pancreatic cancer, adult, Pancreatic Neoplasms

NCT07469956 2026-03-13

Surufatinib Plus mFOLFIRINOX and PD-1 Inhibitor as the Neoadjuvant Therapy for High-risk or Borderline Resectable Pancreatic Cancer

Phase 2 Not yet recruiting

Gastrointestinal

Pancreatic Neoplasms

NCT07444541 2026-03-03

ANO31905 in Combination With Chemotherapy for CLDN18.2-Positive Locally Advanced Unresectable or Metastatic Pancreatic Cancer

Phase 1/2 Not yet recruiting

Gastrointestinal

Pancreatic Neoplasms

NCT07360119 2026-02-25

Total Pancreatectomy With Islet Autotransplantation (TPIAT) for High-Risk Patients With Pancreatic Tumors

Phase NA Not yet recruiting

Gastrointestinal

Pancreatic Neoplasms

NCT07429487 2026-02-24

WATCH AND ACT

Phase NA Not yet recruiting

BreastGastrointestinal

Breast Neoplasms, Fatigue, Pancreatic Neoplasms, Colorectal Neoplasms

NCT07117032 2026-02-19

Simulation-Free Celiac Plexus Pain Ablation Using Stereotactic Body Radiotherapy (SBRT) in Participants With Cancer-Related Celiac Pain

Phase 1 Not yet recruiting

Gastrointestinal

Pancreatic Neoplasms, Abdominal Pain

NCT07422103 2026-02-19

PAN-CLO-BU

Phase NA Not yet recruiting

Gastrointestinal

Pancreatic Diseases, Pancreatic Neoplasms

NCT07415525 2026-02-17

IBI343 Combined With Chemotherapy as Neoadjuvant Therapy in Borderline Resectable Pancreatic Cancer

Phase 2 Not yet recruiting

Gastrointestinal

Pancreatic Neoplasms

NCT07394205 2026-02-06

Clinical Study of CBG131 CAR-T Cell Injection for the Treatment of CLDN18.2-Positive Advanced Gastric and Pancreatic Cancer

Phase EARLY_PHASE1 Not yet recruiting

Gastrointestinal

Pancreatic Neoplasms

NCT06203821 2026-02-05

Study of Perioperative NP137 and FOLFIRINOX in Resectable Pancreatic Cancer

Phase 1 Not yet recruiting

Gastrointestinal

Pancreatic Neoplasms

NCT06217666 2026-02-05

Study Examining the Safety and Toxicity of Stereotactic Body Radiotherapy (SBRT) Followed by PCX12 Immunotherapy Delivered by Intratumoral Injection for the Treatment of Patients With Locally Advanced Pancreatic Adenocarcinoma (LAPC)

Phase 1 Not yet recruiting

Gastrointestinal

Pancreatic Neoplasms

NCT07383922 2026-02-04

A Study of FG-M108+Chemotherapy vs Placebo+Chemotherapy in Claudin18.2-positive Pancreatic Cancer

Phase 3 Not yet recruiting

Gastrointestinal

Pancreatic Neoplasms

NCT07387263 2026-02-04

Mainstreaming Genetics: Evaluation of a Digital Application to Scale and Spread Oncologist-initiated Genetic Testing

Phase NA Not yet recruiting

BreastGastrointestinalGenitourinaryGynecologic

Breast Neoplasms, Colonic Neoplasms, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms

NCT07377526 2026-01-30

Phase 1/2 Study TROP2 CAREngineered Cord Blood-Derived NK Cells + Belzutifan In Pancreatic Cancer

Phase 1/2 Not yet recruiting

Gastrointestinal

Pancreatic Neoplasms

NCT07354919 2026-01-21

AxeCan

Phase 2 Not yet recruiting

BreastGastrointestinalGenitourinaryThoracic

Breast Neoplasms, Lung Neoplasms, Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms

NCT07341737 2026-01-15

SL-28 for Advanced Solid Tumours

Phase 1/2 Not yet recruiting

BreastDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckThoracic

Adenocarcinoma of Lung, Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms, Head and Neck Neoplasms, Intestinal Neoplasms, Kidney Neoplasms, Liver Neoplasms, Lung Neoplasms, Melanoma, Neoplasm Metastasis, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

NCT07325214 2026-01-12

Chemotherapy With or Without IMD10 (Focused Ultrasound) in the Treatment of Borderline Resectable or Locally Advanced Pancreatic Cancer

Phase NA Not yet recruiting

Gastrointestinal

Pancreatic Neoplasms

NCT07126158 2026-01-05

Stereotactic Body Radiotherapy Plus FAK and RAF/MEK Inhibition in Advanced Pancreatic Adenocarcinoma

Phase 2 Not yet recruiting

Gastrointestinal

Pancreatic Neoplasms

NCT07272109 2025-12-15

PTCA199-16

Phase 3 Not yet recruiting

Gastrointestinal

Pancreatic Neoplasms

NCT07262567 2025-12-03

Phase III Study to Compare GFH375 and Chemotherapy in Patients With KRAS G12D-Mutant Metastatic Pancreatic Cancer

Phase 3 Not yet recruiting

Gastrointestinal

Pancreatic Neoplasms

NCT06755359 2025-12-02

Alpha Radiation Emitters Device (DaRT) for the Treatment of Locally Advanced Pancreatic Cancer

Phase NA Not yet recruiting

Gastrointestinal

Pancreatic Neoplasms

NCT06177522 2025-11-18

Adebrelimab Combined With Chemotherapy for Neoadjuvant Therapy in Resectable Pancreatic Cancer

Phase 2 Not yet recruiting

Gastrointestinal

Pancreatic Neoplasms

NCT07219238 2025-10-21

Study to Evaluate the Diagnostic Performance of GEH300079 (68Ga) Injection PET/CT for Detection of PC in Patients With Colorectal, Gastric, Ovarian, or Pancreatic Cancers (PERISCOPE)

Phase 2/3 Not yet recruiting

GastrointestinalGynecologic

Ovarian Neoplasms, Pancreatic Neoplasms, Peritoneal Neoplasms, Stomach Neoplasms, Colorectal Neoplasms

NCT07208539 2025-10-06

ZSPAC-14

Phase 2 Not yet recruiting

Gastrointestinal

Pancreatic Neoplasms

NCT07172503 2025-09-15

Clinical Application of PET Imaging Targeting GPA33 in Malignant Tumors

Phase NA Not yet recruiting

Gastrointestinal

Pancreatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms

NCT07173374 2025-09-15

SCART-P

Phase 1 Not yet recruiting

Gastrointestinal

Pancreatic Neoplasms

NCT07173387 2025-09-15

RAD-NALIRIFOX

Phase 2 Not yet recruiting

Gastrointestinal

Pancreatic Neoplasms

NCT07160283 2025-09-08

The Efficacy and Safety of Trilaciclib in Bone Marrow Protection Before Chemotherapy for Advanced Bile Duct Cancer and Pancreatic Cancer

Phase 2 Not yet recruiting

Gastrointestinal

Biliary Tract Neoplasms, Pancreatic Neoplasms

NCT07153289 2025-09-03

ResCPa

Phase 1/2 Not yet recruiting

Gastrointestinal

Pancreatic Neoplasms, Carcinoma, Pancreatic Ductal

NCT07132060 2025-08-27

MRI-guided Dose Intensification Program Locally Advanced Pancreatic Cancer

Phase NA Not yet recruiting

Gastrointestinal

Pancreatic Neoplasms

NCT07114666 2025-08-11

XH001 (New Antigen Tumor Vaccine) Combined With Chemotherapy as Adjuvant Therapy in Pancreatic Cancer

Phase NA Not yet recruiting

Gastrointestinal

Pancreatic Neoplasms

NCT07026981 2025-08-08

[Ga-68]MTP220 PET for Biodistribution and Efficacy in Pancreatic Cancer and Head and Neck Cancers

Phase EARLY_PHASE1 Not yet recruiting

GastrointestinalHead & Neck

Head and Neck Neoplasms, Pancreatic Neoplasms

NCT07089940 2025-07-29

OMO-103 for the Treatment of Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma

Phase EARLY_PHASE1 Not yet recruiting

Gastrointestinal

Pancreatic Neoplasms

NCT06541561 2025-07-17

Efficacy of TEAS on Postoperative Pain and Recovery in Patients Undergoing Pancreatectomy

Phase NA Not yet recruiting

Gastrointestinal

Pancreatic Neoplasms

NCT07055568 2025-07-09

A Clinical Study Evaluating the Safety, Tolerability, and Preliminary Efficacy of Allogeneic iNKT Cell Infusion in Subjects With Advanced Pancreatic Cancer

Phase NA Not yet recruiting

Gastrointestinal

Pancreatic Neoplasms

NCT07012694 2025-07-01

22G-Adapt vs 22G-Franseen Needle Biopsy in EUS-Guided Tissue Acquisition of Solid Lesions

Phase NA Not yet recruiting

Gastrointestinal

Abdominal Neoplasms, Mediastinal Neoplasms, Pancreatic Neoplasms

NCT04901741 2025-06-27

OPTIMUS

Phase 2 Not yet recruiting

Gastrointestinal

Pancreatic Neoplasms

NCT06999512 2025-05-31

HPB70+

Phase 2/3 Not yet recruiting

Gastrointestinal

Gallbladder Neoplasms, Carcinoma, Hepatocellular, Pancreatic Neoplasms

NCT06991491 2025-05-28

Ivonescimab With GnP and SBRT in Patients With Metastatic Pancreatic Cancer (WGOG-PAN 004)

Phase 2 Not yet recruiting

Gastrointestinal

Pancreatic Neoplasms

NCT06981273 2025-05-20

SPAIN PD

Phase NA Not yet recruiting

Gastrointestinal

Pancreatic Neoplasms

NCT06938282 2025-04-25

An Exploratory Clinical Study of HRS-4642 in Combination With Immunotherapy and Chemotherapy for Pancreatic Cancer

Phase 2 Not yet recruiting

Gastrointestinal

Pancreatic Neoplasms

NCT05041335 2025-04-22

EUS Heparin

Phase NA Not yet recruiting

Gastrointestinal

Esophageal Neoplasms, Liver Neoplasms, Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms

NCT06916975 2025-04-08

CSPAC-48

Phase 2 Not yet recruiting

Gastrointestinal

Pancreatic Neoplasms

NCT06913218 2025-04-06

A Study of mRNA Vaccines AK154 Monotherapy or in Combination With AK104/AK112,and Sequential mFOLFIRINOX in Surgically Resected PDAC

Phase 1 Not yet recruiting

Gastrointestinal

Pancreatic Neoplasms

NCT06911021 2025-04-04

68Ga-FAPI-46 in Staging of Pancreatic Adenocarcinoma

Phase NA Not yet recruiting

Gastrointestinal

Pancreatic Neoplasms

NCT06779318 2025-04-03

Maintenance Chemotherapy With S-1 vs. Observation After Adjuvant Therapy for Resected Pancreatic Cancer With High Risk of Recurrence/Metastasis

Phase 4 Not yet recruiting

Gastrointestinal

Pancreatic Neoplasms

NCT04381130 2025-02-26

A Phase I/IIa Study of EF-009 in Patients with Pancreatic Cancer

Phase 1/2 Not yet recruiting

Gastrointestinal

Pancreatic Neoplasms

NCT06833658 2025-02-19

Effects of Aromatherapy with Essential Oils on Anxiety and Depression in Perioperative Patients with Pancreatic Cancer

Phase NA Not yet recruiting

Gastrointestinal

Anxiety Disorders, Depression, Pancreatic Neoplasms

NCT05562297 2025-01-22

Neoadjuvant/Adjuvant Sintilimab, Nab-paclitaxel, and Gemcitabine for Resectable/Borderline Resectable Pancreatic Cancer

Phase 2 Not yet recruiting

Gastrointestinal

Pancreatic Neoplasms